Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Inaji

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1991
[Tumor markers. Personal experience--screening of breast cancer by determining CEA in nipple discharge]H Inaji, H Koyama
Clinical Orthopaedics and Related Research|March 1, 1995
Prognostic significance of bone metastasis from breast cancerK Yamashita, H Koyama, H Inaji
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 12, 2000
[Tumor markers in breast cancer]H Inaji, Y Komoike, K Motomura, et al.
Oncology Reports|May 21, 2011
Preoperative detection of C-erbb-2 gene amplification as a predictor of local recurrence after conservative treatment for breast-carcinomaK Motomura, H Koyama, S Noguchi, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 12, 2000
[Sentinel node biopsy]K Motomura, Y Komoike, H Inaji, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1989
[A comparison of two doses of tamoxifen in patients with advanced breast cancer: 20 mg/day versus 40 mg/day]Y Takatsuka, E Yayoi, H Inaji, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1997
[Benefits of adjuvant chemotherapy for breast cancer]K Motomura, S Noguchi, H Inaji, et al.
Breast Cancer Research and Treatment|January 1, 1996
Differential distribution of ErbB-2 and pS2 proteins in ductal carcinoma in situ of the breastH Inaji, H Koyama, K Motomura, et al.
Breast Cancer (Tokyo, Japan)|December 15, 2000
Diagnosis of ductal carcinoma in situ (DCIS) and intraductal papilloma using fluorescence in situ hybridization (FISH) analysisY Komoike, K Motomura, H Inaji, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1995
[Prognostic factors for breast cancer]S Noguchi, K Motomura, H Inaji, et al.
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1991
[Tumor markers. Personal experience--screening of breast cancer by determining CEA in nipple discharge]H Inaji, H Koyama
Clinical Orthopaedics and Related Research|March 1, 1995
Prognostic significance of bone metastasis from breast cancerK Yamashita, H Koyama, H Inaji
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 12, 2000
[Tumor markers in breast cancer]H Inaji, Y Komoike, K Motomura, et al.
Oncology Reports|May 21, 2011
Preoperative detection of C-erbb-2 gene amplification as a predictor of local recurrence after conservative treatment for breast-carcinomaK Motomura, H Koyama, S Noguchi, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 12, 2000
[Sentinel node biopsy]K Motomura, Y Komoike, H Inaji, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1989
[A comparison of two doses of tamoxifen in patients with advanced breast cancer: 20 mg/day versus 40 mg/day]Y Takatsuka, E Yayoi, H Inaji, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1997
[Benefits of adjuvant chemotherapy for breast cancer]K Motomura, S Noguchi, H Inaji, et al.
Breast Cancer Research and Treatment|January 1, 1996
Differential distribution of ErbB-2 and pS2 proteins in ductal carcinoma in situ of the breastH Inaji, H Koyama, K Motomura, et al.
Breast Cancer (Tokyo, Japan)|December 15, 2000
Diagnosis of ductal carcinoma in situ (DCIS) and intraductal papilloma using fluorescence in situ hybridization (FISH) analysisY Komoike, K Motomura, H Inaji, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1995
[Prognostic factors for breast cancer]S Noguchi, K Motomura, H Inaji, et al.
Pageof 10